封面
市場調查報告書
商品編碼
1684532

氣管切開產品市場機會、成長動力、產業趨勢分析和 2025 - 2034 年預測

Tracheostomy Products Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: | 出版商: Global Market Insights Inc. | 英文 155 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球氣管切開產品市場價值為 2.17 億美元,預計將大幅成長,預計 2025 年至 2034 年期間的複合年成長率為 5.1%。這種擴張源於多種因素,包括氣管切開技術的進步、兒科呼吸道疾病盛行率的增加、呼吸照護意識的提高以及人口老化的成長。由於重症監護入院人數增加和慢性呼吸系統疾病負擔加重,對呼吸照護解決方案的需求不斷增加,進一步凸顯了市場的潛力。此外,氣管切開產品的持續創新,例如抗菌塗層、無袖口設計和靈活的客製化管,正在滿足患者對安全性、舒適性和效率的關鍵需求。全球各地的醫療機構擴大採用這些尖端技術,凸顯了市場的發展前景。

氣管切開產品市場 - IMG1

市場按產品類型分類,包括氣管切開管、通氣配件、清潔和護理套件以及其他相關產品。氣管切開管佔據了市場主導地位,2024 年市場價值為 1.123 億美元。這些管子對於氣道狀況的管理仍然至關重要,因為它們有助於有效通氣,同時最大限度地減少併發症。氣管切開管的技術進步,例如抗菌材料和創新設計,正在改善患者的治療效果並提高長期呼吸護理的整體安全性。此外,創傷、中風和嚴重感染引起的重症監護病例不斷增加,也增加了醫院和家庭護理環境中對氣管切開管的需求。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 2.17億美元
預測值 3.504 億美元
複合年成長率 5.1%

市場也按技術細分,經皮擴張氣管切開術和手術氣管切開術是兩種主要方法。經皮擴張氣管切開術在 2024 年的收入為 1.312 億美元,由於其微創性質而成為首選技術。此方法只需一個小切口並使用擴張器來擴大氣管,從而減少組織損傷、加快恢復時間並降低併發症的風險。重症監護環境中對這項技術的日益青睞反映了其有效性和對微創手術的日益成長的需求。

美國氣管切開產品市場在 2024 年創造了 8,050 萬美元的產值,預計在 2025 年至 2034 年期間的複合年成長率為 4.6%。美國在醫療技術創新方面處於領先地位,特別是在開發先進的氣管切開解決方案方面,例如抗菌管、無袖口管和一次性管。這些進步提高了病患的安全性和舒適度,推動了醫院和居家照護環境中的採用。此外,長期呼吸照護的優惠報銷政策確保了高品質氣管切開產品的可近性,進一步推動了市場成長。

目錄

第 1 章:方法論與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業衝擊力
    • 成長動力
      • 呼吸系統疾病發生率不斷上升
      • 新興市場醫療支出不斷成長
      • 氣管切開產品的技術進步
      • 外科手術增多
    • 產業陷阱與挑戰
      • 先進產品成本高
      • 併發症風險
  • 成長潛力分析
  • 監管格局
  • 技術格局
  • 報銷場景
  • 波特的分析
  • PESTEL 分析
  • 差距分析
  • 價值鏈分析

第4章:競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 策略儀表板

第5章:市場估計與預測:依產品類型,2021 年至 2034 年

  • 主要趨勢
  • 氣管切開管
    • 帶套囊的氣管切開插管
    • 無套囊氣管切開插管
    • 有孔氣管切開管
    • 無孔氣管切開管
  • 通風配件
  • 清潔及護理套件
  • 其他產品類型

第6章:市場估計與預測:按技術,2021 年至 2034 年

  • 主要趨勢
  • 經皮擴張氣管切開術
  • 外科氣管切開術

第 7 章:市場估計與預測:按病患類型,2021 — 2034 年

  • 主要趨勢
  • 成人
  • 兒科

第 8 章:市場估計與預測:依最終用途,2021 年至 2034 年

  • 主要趨勢
  • 醫院
  • 專科診所
  • 門診手術中心
  • 其他最終用戶

第9章:市場估計與預測:按地區,2021 年至 2034 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第10章:公司簡介

  • Andreas FAHL
  • ANGIPLAST
  • Atos
  • Boston Medical
  • ConvaTec
  • COOK MEDICAL
  • Fisher & Paykel
  • Fuji Systems
  • MEDIS MEDICAL
  • Medtronic
  • Pulmodyne
  • Smiths Group
  • Teleflex
  • TROGE
  • wellead
簡介目錄
Product Code: 12941

The Global Tracheostomy Products Market, valued at USD 217 million in 2024, is poised for significant growth with a projected CAGR of 5.1% between 2025 and 2034. This expansion stems from various factors, including advancements in tracheostomy technology, the increasing prevalence of pediatric airway disorders, rising awareness of respiratory care, and the growing aging population. The escalating demand for respiratory care solutions, driven by an increase in critical care admissions and the rising burden of chronic respiratory conditions, further underscores the market's potential. Moreover, continuous innovations in tracheostomy products, such as antimicrobial coatings, cuffless designs, and flexible customized tubes, are addressing key patient needs for safety, comfort, and efficiency. The growing adoption of these cutting-edge technologies by healthcare facilities worldwide highlights the market's promising trajectory.

Tracheostomy Products Market - IMG1

The market is categorized by product type, encompassing tracheostomy tubes, ventilation accessories, clean and care kits, and other related products. Tracheostomy tubes dominated the market, generating USD 112.3 million in 2024. These tubes remain integral to the management of airway conditions, as they facilitate effective ventilation while minimizing complications. Technological advancements in tracheostomy tubes, such as antimicrobial materials and innovative designs, are enhancing patient outcomes and improving the overall safety of long-term respiratory care. Additionally, the rising number of critical care cases caused by trauma, strokes, and severe infections has amplified the need for tracheostomy tubes in both hospital and home care settings.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$217 Million
Forecast Value$350.4 Million
CAGR5.1%

The market is also segmented by technique, with percutaneous dilatational tracheostomy and surgical tracheostomy as the two primary methods. Percutaneous dilatational tracheostomy accounted for USD 131.2 million in 2024, emerging as the preferred technique due to its minimally invasive nature. This method involves a small incision and the use of a dilator to enlarge the trachea, which results in less tissue damage, faster recovery times, and a lower risk of complications. The growing preference for this technique in critical care settings reflects its effectiveness and the increasing demand for minimally invasive procedures.

The U.S. tracheostomy products market generated USD 80.5 million in 2024 and is expected to grow at a CAGR of 4.6% between 2025 and 2034. The United States leads in medical technology innovation, particularly in developing advanced tracheostomy solutions such as antimicrobial, cuffless, and disposable tubes. These advancements enhance patient safety and comfort, driving adoption in hospital and home care environments. Additionally, favorable reimbursement policies for long-term respiratory care ensure accessibility to high-quality tracheostomy products, further fueling market growth.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing incidence of respiratory disorders
      • 3.2.1.2 Growing healthcare expenditure in emerging markets
      • 3.2.1.3 Technological advancements in tracheostomy products
      • 3.2.1.4 Rise in surgical procedures
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost associated with advanced products
      • 3.2.2.2 Risk of complications
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Reimbursement scenario
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis
  • 3.9 Gap analysis
  • 3.10 Value chain analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 — 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Tracheostomy tubes
    • 5.2.1 Cuffed tracheostomy tubes
    • 5.2.2 Uncuffed tracheostomy tubes
    • 5.2.3 Fenestrated tracheostomy tubes
    • 5.2.4 Non-fenestrated tracheostomy tubes
  • 5.3 Ventilation accessories
  • 5.4 Clean & care kits
  • 5.5 Other product types

Chapter 6 Market Estimates and Forecast, By Technique, 2021 — 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Percutaneous dilatational tracheostomy
  • 6.3 Surgical tracheostomy

Chapter 7 Market Estimates and Forecast, By Patient Type, 2021 — 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Adult
  • 7.3 Pediatric

Chapter 8 Market Estimates and Forecast, By End Use, 2021 — 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Specialty clinics
  • 8.4 Ambulatory surgical centers
  • 8.5 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2021 — 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 Andreas FAHL
  • 10.2 ANGIPLAST
  • 10.3 Atos
  • 10.4 Boston Medical
  • 10.5 ConvaTec
  • 10.6 COOK MEDICAL
  • 10.7 Fisher & Paykel
  • 10.8 Fuji Systems
  • 10.9 MEDIS MEDICAL
  • 10.10 Medtronic
  • 10.11 Pulmodyne
  • 10.12 Smiths Group
  • 10.13 Teleflex
  • 10.14 TROGE
  • 10.15 wellead